Miss Emily Gruber
Honorary Conjoint Fellow
The Sir Peter MacCallum Department of Oncology
12 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
Discovery and Characterization of VPRBP/DCAF1 Kinase Inhibitor Analogs as Microtubular Destabilizing Agents with Potent Antimyeloma Activity
DOI: 10.1158/1535-7163.MCT-25-03062026
Journal article
Epigenetic reprogramming in multiple myeloma—Challenges and opportunities
DOI: 10.1002/ijc.354262026
Journal article
Inhibition of heme biosynthesis triggers cuproptosis in acute myeloid leukemia
DOI: 10.1016/j.cell.2025.10.0282023
Journal article
The curious case of IDH mutant acute myeloid leukaemia: biochemistry and therapeutic approaches
DOI: 10.1042/BST202300172023
Journal article
Functional and Phenotypic Characterisations of Common Syngeneic Tumour Cell Lines as Estrogen Receptor-Positive Breast Cancer Models
DOI: 10.3390/ijms240656662023
Journal article
Rationally designed chimeric PI3K-BET bromodomain inhibitors elicit curative responses in MYC-driven lymphoma
DOI: 10.1073/pnas.23064141202022
Journal article
Inhibition of mutant IDH1 promotes cycling of acute myeloid leukemia stem cells
DOI: 10.1016/j.celrep.2022.111182
RECENT SCHOLARLY WORKS
2022
Journal article
Inhibition of pyrimidine biosynthesis targets protein translation in acute myeloid leukemia
DOI: 10.15252/emmm.2021152032022
Journal article
Integrated clinical and genomic evaluation of guadecitabine (SGI-110) in peripheral T-cell lymphoma
DOI: 10.1038/s41375-022-01571-82021
Journal article
Serine biosynthesis is a metabolic vulnerability in flt3-itd–driven acute myeloid leukemia
DOI: 10.1158/2159-8290.CD-20-0738